ABI.BR stock is trading in pre-market on 07 Feb 2026 at €64.26 as investors position ahead of Anheuser-Busch InBev SA/NV’s earnings cycle. The company reports on 12 Feb 2026, and sentiment is tracking margins, premium-brand growth and B2B channel trends. Key pre-market data: PE 25.20, EPS €2.55, market cap €124.88B, and volume 2,285,146. This earnings spotlight looks at near-term catalysts, valuation context on EURONEXT (Europe), and what numbers could move the stock when markets open.

ABI.BR stock: earnings preview and timing

Anheuser-Busch InBev will report results on 12 Feb 2026 (Earnings Announcement: 2026-02-12 16:40:00+00:00). Pre-market activity on 07 Feb 2026 reflects cautious positioning after recent margin improvements tied to premiumisation and digital B2B growth. Investors should watch organic revenue growth, gross margin, and regional volumes in North America and Asia Pacific, which drive consensus surprises and guide near-term multiples.

Latest price action and key financial metrics

The stock sits at €64.26 with a day range €63.66–€64.58 and year range €48.67–€64.58. Trading volume is 2,285,146 vs average 1,619,500, showing above-average interest. Key metrics: EPS €2.55, PE 25.20, 50-day average price €56.25, 200-day average €55.79, and dividend per share TTM €0.95 (yield ~1.25%). These figures link directly to valuation and will be re-priced on any earnings surprise.

Operational drivers, risks and sector context

ABI.BR’s performance reflects premium-brand pricing, BEES B2B uptake and regional mix. Consumer Defensive peers show average PE ~24.29, so ABI.BR’s PE 25.20 is roughly in line with sector norms. Risks include currency swings, tariffs in key markets and leverage (netDebt/EBITDA ~2.91). Watch cost inflation, promotional intensity and summer ad spending as near-term drivers of margin outcomes.

Meyka AI rates ABI.BR with a score out of 100 and technical read

Meyka AI rates ABI.BR with a score of 71.16 out of 100 (Grade B+, Suggestion: BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Technicals show RSI 51.61, MACD histogram slightly negative, ATR €1.05, and Money Flow Index 80.68 suggesting short-term overbought conditions. These readings support cautious buying ahead of results.

Valuation, analyst context and price targets

Current market cap is €124.88B and price-to-sales is ~1.99. Institutional notes highlight premiumisation and margin expansion as bull cases. Consensus price target is not published in the feed, so model-driven targets matter more now. Expect updates from major brokers after the release; watch implied move versus ABI.BR’s historical earnings-day volatility.

Short-term forecast, trade setup and news links

For traders, a short window trade could target earnings-driven volatility with tight risk control. Watch support near €56.25 (50-day MA) and resistance at the year high €64.58. Recent sources and market context: see coverage on CNBC and trading history at Investing.com. Meyka AI provides this pre-market snapshot as an AI-powered market analysis platform.

Final Thoughts

Key takeaways: ABI.BR stock trades at €64.26 on EURONEXT in pre-market on 07 Feb 2026 as investors position ahead of the 12 Feb 2026 earnings report. Fundamentals show EPS €2.55 and PE 25.20, with market cap €124.88B and above-average volume 2,285,146 that signals stronger interest. Meyka AI’s forecast model projects a short-term (monthly) price of €67.93, implying a +5.71% upside from the current price, and a yearly model price of €55.84, implying -13.11% downside. Meyka AI rates ABI.BR with a score of 71.16/100 (Grade B+, Suggestion: BUY) reflecting sector positioning and recent growth trends. Forecasts are model-based projections and not guarantees. Watch margins, regional volumes and management guidance on the report day; these items will set the next directional move for traders and longer-term investors alike.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.